(Q44170376)

30 November 2017

title

Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung (English)

1 reference

30 November 2017

1 reference

Ken-ichiro Minami

1

1 reference

30 November 2017

Yukihito Saito

series ordinal

2

1 reference

30 November 2017

Hiroji Imamura

series ordinal

3

1 reference

30 November 2017

Akiharu Okamura

series ordinal

4

1 reference

30 November 2017

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

38

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

51-57

1 reference

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Postoperative adjuvant therapy for stage IB non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Biological prognostic factors for early stage completely resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Prognostic molecular markers in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Molecular biologic substaging of stage I lung cancer according to gender and histology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

The relationship of p53 immunostaining to survival in carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Ki-67 immunostaining and survival in operable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Prognostic significance of Ki67 labelling in resected non small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

1 reference

7 January 2021

Vascular permeability factor (VPF, VEGF) in tumor biology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Angiogenesis in primary lung cancer and lung secondaries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

Growth factors, mitogens, oncogenes and the regulation of glucose transport

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900108-3

7 January 2021

10.1016/S0169-5002(02)00108-3

Identifiers

DOI

1 reference

30 November 2017

1 reference